SLV318, a novel agonist for the dopamine D2 and D3 receptor:: In vitro and in vivo neurochenical characterization

被引：0
|
作者：
Hesselink, MB
van der Neut, M
Adolfs, T
Feenstra, R
Long, S
van Scharrenburg, G
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P170
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [21] Dopamine D2/D3 receptor availability and venturesomeness
    Bernow, Nina
    Yakushev, Igor
    Landvogt, Christian
    Buchholz, Hans-Georg
    Smolka, Michael N.
    Bartenstein, Peter
    Lieb, Klaus
    Gruender, Gerhard
    Vernaleken, Ingo
    Schreckenberger, Mathias
    Fehr, Christoph
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2011, 193 (02) : 80 - 84
  • [22] On dopamine D2 and D3 receptor pharmacology - Ekman,A
    不详
    NORDIC JOURNAL OF PSYCHIATRY, 1996, 50 (06) : 499 - 500
  • [23] Neurochemical and behavioural actions of a novel dopamine D3/D2 receptor antagonist/partial agonist putative antipsychotic
    Kiss, B.
    Gyertyan, I.
    Saghy, K.
    Laszlovszky, I
    Horvath, A.
    Laszy, J.
    Schmidt, E.
    Szabo, Gy
    Againe, Csongor E.
    Adham, N.
    Tihanyi, K.
    Szombathelyi, Zs
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (09) : 1274 - 1275
  • [24] Talipexole variations as novel bitopic dopamine D2 and D3 receptor ligands
    Stank, Lars
    Frank, Annika
    Hagenow, Stefanie
    Stark, Holger
    MEDCHEMCOMM, 2019, 10 (11) : 1926 - 1929
  • [25] Aromatic linker variations in novel dopamine D2 and D3 receptor ligands
    Di Biase, Cristian
    Leitzbach, Luisa
    Frank, Annika
    Zivkovic, Aleksandra
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2024, 357 (08)
  • [26] Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
    Kiss, Bela
    Horvath, Attila
    Nemethy, Zsolt
    Schmidt, Eva
    Laszlovszky, Istvan
    Bugovics, Gyula
    Fazekas, Karoly
    Hornok, Katalin
    Orosz, Szabolcs
    Gyertyan, Istvan
    Agai-Csongor, Eva
    Domany, Gyoergy
    Tihanyi, Karoly
    Adham, Nika
    Szombathelyi, Zsolt
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 328 - 340
  • [27] Effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5-HT1A receptor agonist, on rat dopamine and serotonin neuronal activity
    Betry, C.
    Etievant, A.
    Lambas-Senas, L.
    McCreary, A.
    Haddjeri, N.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S117 - S117
  • [28] In vivo characterization of a novel dopamine D3 receptor agonist to treat motor symptoms of Parkinson's disease
    Simms, Sherise L.
    Huettner, Daniel P.
    Kortagere, Sandhya
    NEUROPHARMACOLOGY, 2016, 100 : 106 - 115
  • [29] Effects of dopamine D3/D2 receptor agonists on body temperature and locomotion in dopamine D3 or D2 receptor knock-out mice
    Boulay, D
    Depoortere, R
    Perrault, G
    Sanger, DJ
    BRAIN RESEARCH, 1998, 809 (01) : A25 - A25
  • [30] In vivo Behavioral Characterization of ML417, a Novel D3 Dopamine Receptor-selective Agonist
    Akano, Emmanuel Oladele
    Moritz, Amy Elizabeth
    Preston, Michael Wayne
    Lobb, Collin Jethro
    Du Hoffmann, Johann Faustus
    Free, R. Benjamin
    Frankowski, Kevin J.
    Walters, Judith R.
    Sibley, David R.
    FASEB JOURNAL, 2018, 32 (01):
12345